Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 622353
                    [Title] => GSK launches first drug to reduce prostate cancer risk in the country
                    [Summary] => 
GlaxoSmithKline (GSK) recently announced an important milestone in the Philippines with the launch of the new indication of dutasteride, a drug that has been shown to lower the risk of prostate cancer by 23 percent overall.
                    [DatePublished] => 2010-10-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DR. GERALD ANDRIOLE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 622353
                    [Title] => GSK launches first drug to reduce prostate cancer risk in the country
                    [Summary] => 
GlaxoSmithKline (GSK) recently announced an important milestone in the Philippines with the launch of the new indication of dutasteride, a drug that has been shown to lower the risk of prostate cancer by 23 percent overall.
                    [DatePublished] => 2010-10-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

GSK launches first drug to reduce prostate cancer risk in the country

October 21, 2010 - 12:00am

GlaxoSmithKline (GSK) recently announced an important milestone in the Philippines with the launch of the new indication of dutasteride, a drug that has been shown to lower the risk of prostate cancer by 23 percent...

Science and Environment